Effects of Cisplatin on the Radiation Response and DNA Damage Markers in Peripheral Blood Lymphocytes Ex Vivo
Cells · 2025
DOI: 10.3390/cells14100682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Sebastian Zahnreich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Radiation Therapy, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Cisplatin, Lymphocytes, DNA Damage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Education and Research.
Abstract (Originalsprache)
Platinum-based radiochemotherapy is associated with hematologic side effects, impacting patient outcomes. However, the clinical mechanisms of cisplatin and its interaction with ionizing radiation (IR), including in biodosimetry for radiotherapy, have not yet been fully clarified. For this purpose, healthy donors’ peripheral blood lymphocytes (PBLs) were pretreated with cisplatin in a pulse (1–4 h) or continuous (24 h) regimen followed by X-rays. DNA damage was assessed as DNA double-strand breaks using repair foci of γH2AX and 53BP1 after 0.5 h and 24 h in G1 PBLs and a proliferation-based cytokinesis-block micronucleus assay. Additionally, cell death and proliferation activity were measured. Unlike a 1 h pulse, a 24 h cisplatin pretreatment caused a concentration-dependent increase in cisplatin-induced foci while decreasing IR-induced foci, especially 24 h after irradiation. This was accompanied by increased apoptosis, with cisplatin and IR having additive effects. Both genotoxins alone caused a dose-dependent increase in micronuclei, while cisplatin significantly reduced binuclear cells, especially after the 24 h treatment, leading to lower micronuclei frequencies post-irradiation. Our results show that prolonged cisplatin exposure, even at low concentrations, impacts the vitality and division activity of PBLs, with significantly stronger effects post-irradiation. This has major implications and must be considered for the detection of DNA damage-associated biomarkers in PBLs used in clinical prediction or biodosimetry during radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology and Radiation Therapy, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
ORCID-Profile: Sebastian Zahnreich, Justus Kaufmann
Förderung
- German Federal Ministry of Education and Research
Zitieren
APA
Zahnreich, S., Bhatti, A., Ahmad, B., Drabke, S., Kaufmann, J., & Schmidberger, H. (2025). Effects of Cisplatin on the Radiation Response and DNA Damage Markers in Peripheral Blood Lymphocytes Ex Vivo. Cells. https://doi.org/10.3390/cells14100682
Vancouver
Zahnreich S, Bhatti A, Ahmad B, Drabke S, Kaufmann J, Schmidberger H. Effects of Cisplatin on the Radiation Response and DNA Damage Markers in Peripheral Blood Lymphocytes Ex Vivo. Cells. 2025. doi:10.3390/cells14100682
BibTeX
@article{Zahnreich2025,
author = {Zahnreich, Sebastian and Bhatti, Aisha and Ahmad, Barea and Drabke, Sophia and Kaufmann, Justus and Schmidberger, Heinz},
title = {Effects of Cisplatin on the Radiation Response and DNA Damage Markers in Peripheral Blood Lymphocytes Ex Vivo},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14100682}
}
EUVIMED